Drawing for PHARMAREP.COM

USPTO serial 76185422

PHARMAREP.COM

Reviewed by CopyMark Law Group

Status 601
Filing date
Status date
Registration date
—
Examiner
ALVES, RICHARD
Law office
FILE REPOSITORY (FRANCONIA)

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with PHARMAREP.COM?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

GERALD J. FERGUSON

GERALD J FERGUSON THACHER, PROFITT & WOOD11 W 42D STNEW YORK, NY 10036UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
035Computerized on-line retail services in the field of pharmaceutical, medical and healthcare information, equipment and supplies, namely books, journals, computer software, apparel, medical supplies and equipment, medical office supplies and equipment, study aids for students in healthcare and allied fields, and protective wearACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jan 24, 2002ABN1ABANDONMENT - EXPRESS MAILED—
Oct 22, 2001CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Apr 26, 2001CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 18, 2001DOCKASSIGNED TO EXAMINER—
Apr 2, 2001DOCKASSIGNED TO EXAMINER—

Frequently asked questions

Related guidance